FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula in free form or in form of a pharmaceutically acceptable salt, where T denotes C1-C10alkyl which is substituted in one position with a -NR1R2 group or C3-C15carboxylic group selected from indan, phenyl, C3-C8cycloalkyl, wherein said C3-C15carboxylic group is optionally substituted in one or two positions with a halogen group, -NR3R4 or C1-C10alkoxy group, or T denotes C3-C15carboxylic group selected from indan, phenyl, C5cycloalkyl which is optionally substituted in one or two positions with a C1-C10alkyl group, C5cycloalkyl or C1-C10alkoxy group which is optionally substituted in one position with phenyl, and R1, R2 independently denote C1-C10alkyl or phenyl, and R3, R4 independently denote C1-C10alkyl. The formula I compound has β2-adrenoreceptor agonist activity.
EFFECT: more effective use as an active ingredient of a pharmaceutical composition.
7 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PYRROLIDINIUM DERIVATIVES AS M3 MUSCARINIC RECEPTORS | 2005 |
|
RU2412183C2 |
COMBINATIONS OF GLUCOPYRROLATE AND B-2 ADRENOCEPTOR ANTOGONISTS | 2005 |
|
RU2388465C2 |
SPECIFIC GLYCOCORTICOSTEROID COMPOUND WITH ANTIINFLAMMATORY EFFECT | 2004 |
|
RU2359973C2 |
ENANTIOSELECTIVE METHOD FOR SYNTHESIS OF QUINOLINE DERIVATIVES | 2005 |
|
RU2383534C2 |
METHOD FOR INHIBITION OF RAF KINASE-MEDIATED GROWTH OF TUMOR CELLS, HETEROCYCLIC UREA DERIVATIVES (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) | 1998 |
|
RU2232015C2 |
COMPOUNDS, METHOD FOR PREPARING COMPOUND, PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2244709C2 |
BENZOTHIAZOLE DERIVATIVES WITH PROPERTIES OF BETTA-2-ADRENORECEPTOR AGONISTS | 2003 |
|
RU2324687C2 |
IMIDAZOLE VERSIONS AS MODULATORS OF GAMMA-AMINOBUTYRIC ACID (GABA) RECEPTOR FOR TREATING GASTROINTESTINAL (GI) | 2005 |
|
RU2389722C2 |
SPECIFIC GLYCOCOTRICOSTEROID COMPOUND WITH ANTIINFLAMMATORY EFFECT | 2004 |
|
RU2348645C2 |
ARYL- AND HETEROARYL-SUBSTITUTED HETEROCYCLIC DERIVATIVES OF UREA, METHOD FOR INHIBITION OF RAF KINASE ACTIVITY AND PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2265597C2 |
Authors
Dates
2010-10-27—Published
2005-11-28—Filed